Applied UV, Inc.
AUVIQ
$0.0001
$0.000.00%
| Weiss Ratings | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 14.77 | |||
| Price History | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -99.99% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Aug 02, 2024 | |||
| 52-Week High Price (Date) | Mar 07, 2024 | |||
| Valuation | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 428.00 | |||
| Enterprise Value | 11.46M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -67.03 | |||
| Earnings Per Share Growth | -62.08% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 0.28 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -1.13 | |||
| Enterprise Value/EBIT | -0.88 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 786.90K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -5.83% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 914 665 6100 | |||
| Address | 150 North Macquesten Parkway Mount Vernon, NY 10550 | |||
| Website | www.applieduvinc.com | |||
| Country | United States | |||
| Year Founded | 2019 | |||
| Profitability | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -32.16% | |||
| Profit Margin | -32.42% | |||
| Management Effectiveness | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -17.97% | |||
| Return on Equity | -- | |||
| Income Statement | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 40.72M | |||
| Total Revenue (TTM) | 40.72M | |||
| Revenue Per Share | $51.75 | |||
| Gross Profit (TTM) | 7.83M | |||
| EBITDA (TTM) | -10.12M | |||
| EBIT (TTM) | -13.10M | |||
| Net Income (TTM) | -13.20M | |||
| Net Income Avl. to Common (TTM) | -13.97M | |||
| Total Revenue Growth (Q YOY) | 55.46% | |||
| Earnings Growth (Q YOY) | 66.82% | |||
| EPS Diluted (TTM) | -67.03 | |||
| EPS Diluted Growth (Q YOY) | 95.29% | |||
| Balance Sheet | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.13M | |||
| Cash Per Share (Q) | $1.44 | |||
| Total Current Assets (Q) | 17.02M | |||
| Total Preferred Equity (Q) | 4.78 | |||
| Total Equity (Q) | 24.88M | |||
| Current Ratio (Q) | 0.611 | |||
| Book Value Per Share (Q) | $11.98 | |||
| Total Assets (Q) | 58.39M | |||
| Total Current Liabilities (Q) | 27.87M | |||
| Total Debt (Q) | 7.81M | |||
| Total Liabilities (Q) | 33.50M | |||
| Total Common Equity (Q) | 20.11M | |||
| Cash Flow | AUVIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -4.84M | |||
| Cash from Financing (TTM) | 11.46M | |||
| Net Change in Cash (TTM) | -1.60M | |||
| Levered Free Cash Flow (TTM) | 7.16M | |||
| Cash from Operations (TTM) | -8.22M | |||
